What does Dokter I. Kindts, Radiotherapie do?

Dokter I. Kindts, Radiotherapie is a specialist medical practice in Wevelgem. Private Limited, started on 27 April 2020, 1 establishment.

What is the address of Dokter I. Kindts, Radiotherapie?

The registered office of Dokter I. Kindts, Radiotherapie is located at Hoge Akker 7, 8560 Wevelgem.

Is Dokter I. Kindts, Radiotherapie still active?

Yes. According to the CBE (26 September 2026) Dokter I. Kindts, Radiotherapie is active, legal situation “Normale toestand”, started on 27 April 2020.

Is Dokter I. Kindts, Radiotherapie registered on Peppol?

Yes, Dokter I. Kindts, Radiotherapie is registered on the Peppol network with ID 0208:0746523084.

What is the enterprise number of Dokter I. Kindts, Radiotherapie?

The enterprise number of Dokter I. Kindts, Radiotherapie is BE0746523084.

When was Dokter I. Kindts, Radiotherapie founded?

Dokter I. Kindts, Radiotherapie was founded on 27 April 2020.

Who are the directors of Dokter I. Kindts, Radiotherapie?

According to the 2025 annual accounts, the directors of Dokter I. Kindts, Radiotherapie are: Isabelle Kindts.

Is Dokter I. Kindts, Radiotherapie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter I. Kindts, Radiotherapie make in 2025?

Dokter I. Kindts, Radiotherapie posted a profit after taxes of € 501,719 in financial year 2025.

What is the revenue of Dokter I. Kindts, Radiotherapie?

As a small company, Dokter I. Kindts, Radiotherapie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 589,006.

Dokter I. Kindts, Radiotherapie (Private Limited)

Dossier Dokter I. Kindts, Radiotherapie, printed on 26 September 2026 from databakkes.be/en/0746523084/dokter-i-kindts-radiotherapie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter I. Kindts, Radiotherapie from Wevelgem, company number BE0746523084, closed financial year 2025 with a result of € 501,719 after tax. For that financial year Dokter I. Kindts, Radiotherapie recorded a gross margin of € 589,006 and equity of € 590,351. Compared with financial year 2024, the result moved from € 422,623 to € 501,719. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 590,351

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 501,719

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 114,220

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 400,000 paid out

80 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 6,873

▼ 11% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,178

▼ 3% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,102

▲ € 1,006 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 60,960

▲ 84% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 452,313 Gross margin 2022: € 452,313 First fiscal year in the series	€ 541,121 Gross margin 2023: € 541,121 ▲ 20% vs 2022 (€ 452,313) Favourable step	€ 555,577 Gross margin 2024: € 555,577 ▲ 3% vs 2023 (€ 541,121) Favourable step	€ 589,006 Gross margin 2025: € 589,006 ▲ 6% vs 2024 (€ 555,577) Favourable step	▲ 6%
Profit after taxes	€ 309,685 Profit after taxes 2022: € 309,685 First fiscal year in the series	€ 413,879 Profit after taxes 2023: € 413,879 ▲ 34% vs 2022 (€ 309,685) Favourable step	€ 422,623 Profit after taxes 2024: € 422,623 ▲ 2% vs 2023 (€ 413,879) Favourable step	€ 501,719 Profit after taxes 2025: € 501,719 ▲ 19% vs 2024 (€ 422,623) Favourable step	▲ 19%
Equity	€ 727,130 Equity 2022: € 727,130 First fiscal year in the series	€ 1,141,009 Equity 2023: € 1,141,009 ▲ 57% vs 2022 (€ 727,130) Favourable step	€ 488,632 Equity 2024: € 488,632 ▼ 57% vs 2023 (€ 1,141,009) Unfavourable step	€ 590,351 Equity 2025: € 590,351 ▲ 21% vs 2024 (€ 488,632) Favourable step	▲ 21%
Total debts	€ 227,728 Total debts 2022: € 227,728 First fiscal year in the series	€ 136,701 Total debts 2023: € 136,701 ▼ 40% vs 2022 (€ 227,728) Favourable step	€ 335,292 Total debts 2024: € 335,292 ▲ 145% vs 2023 (€ 136,701) Unfavourable step	€ 67,132 Total debts 2025: € 67,132 ▼ 80% vs 2024 (€ 335,292) Favourable step	▼ 80%
Cash	€ 434,931 Cash 2022: € 434,931 First fiscal year in the series	€ 599,115 Cash 2023: € 599,115 ▲ 38% vs 2022 (€ 434,931) Favourable step	€ 268,242 Cash 2024: € 268,242 ▼ 55% vs 2023 (€ 599,115) Unfavourable step	€ 114,220 Cash 2025: € 114,220 ▼ 57% vs 2024 (€ 268,242) Unfavourable step	▼ 57%
Retained profit	€ 724,130 Retained profit 2022: € 724,130 First fiscal year in the series	€ 1,138,009 Retained profit 2023: € 1,138,009 ▲ 57% vs 2022 (€ 724,130) Favourable step	€ 485,632 Retained profit 2024: € 485,632 ▼ 57% vs 2023 (€ 1,138,009) Unfavourable step	€ 587,351 Retained profit 2025: € 587,351 ▲ 21% vs 2024 (€ 485,632) Favourable step	▲ 21%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 1,075,000 Dividend 2024: € 1,075,000 Unchanged (€ 0) Unchanged	€ 400,000 Dividend 2025: € 400,000 ▼ 63% vs 2024 (€ 1,075,000) Unchanged	▼ 63%
Balance sheet total	€ 954,858 Balance sheet total 2022: € 954,858 First fiscal year in the series	€ 1,277,710 Balance sheet total 2023: € 1,277,710 ▲ 34% vs 2022 (€ 954,858) Unchanged	€ 823,925 Balance sheet total 2024: € 823,925 ▼ 36% vs 2023 (€ 1,277,710) Unchanged	€ 657,484 Balance sheet total 2025: € 657,484 ▼ 20% vs 2024 (€ 823,925) Unchanged	▼ 20%

Key figures of Dokter I. Kindts, Radiotherapie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter I. Kindts, Radiotherapie?

What happened at Dokter I. Kindts, Radiotherapie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 501,719 (▲ 19% vs 2024). Source: NBB ↗
Apr 27, 2020 New establishment in Wevelgem. KBO
Apr 27, 2020 Start of the company according to the CBE. KBO
2020 Isabelle Kindts became a director. NBB

In short

From € 309,685 profit in 2022 to € 501,719 profit in 2025.

Paid € 513,512 in corporate taxes since 2022.

Best year ever: 2025, with € 501,719 profit.

Paid out € 1.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter I. Kindts, Radiotherapie? We notify you, reason included.

Follow Dokter I. Kindts, Radiotherapie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle Kindts

Dokter I. Kindts, Radiotherapie

Behind Dokter I. Kindts, Radiotherapie is Isabelle Kindts.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle Kindts

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Hoge Akker 7

8560 Wevelgem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

GRR INVEST

€ -10,568 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0746.523.084
VAT number: BE 0746.523.084
Registered office: Hoge Akker 7, 8560 Wevelgem
Names & denominations: Dokter I. Kindts, Radiotherapie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 April 2020
Peppol: Active · Active since 17 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗